- Home
- CNVS vs ITRM Comparison
CNVS vs ITRM Comparison
Compare CNVS & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNVS
- ITRM
- Stock Information
- Founded
- CNVS 2000
- ITRM 2015
- Country
- CNVS United States
- ITRM Ireland
- Employees
- CNVS N/A
- ITRM N/A
- Industry
- CNVS Consumer Electronics/Video Chains
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- CNVS Consumer Discretionary
- ITRM Health Care
- Exchange
- CNVS Nasdaq
- ITRM Nasdaq
- Market Cap
- CNVS 56.2M
- ITRM 49.5M
- IPO Year
- CNVS 2003
- ITRM 2018
- Fundamental
- Price
- CNVS $3.54
- ITRM $1.54
- Analyst Decision
- CNVS Buy
- ITRM Strong Buy
- Analyst Count
- CNVS 1
- ITRM 1
- Target Price
- CNVS $10.00
- ITRM $5.00
- AVG Volume (30 Days)
- CNVS 104.5K
- ITRM 671.4K
- Earning Date
- CNVS 02-12-2025
- ITRM 11-14-2024
- Dividend Yield
- CNVS N/A
- ITRM N/A
- EPS Growth
- CNVS N/A
- ITRM N/A
- EPS
- CNVS N/A
- ITRM N/A
- Revenue
- CNVS $45,005,000.00
- ITRM N/A
- Revenue This Year
- CNVS $50.96
- ITRM N/A
- Revenue Next Year
- CNVS N/A
- ITRM N/A
- P/E Ratio
- CNVS N/A
- ITRM N/A
- Revenue Growth
- CNVS N/A
- ITRM N/A
- 52 Week Low
- CNVS $0.72
- ITRM $0.81
- 52 Week High
- CNVS $4.19
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- CNVS 49.00
- ITRM 39.39
- Support Level
- CNVS $3.34
- ITRM $1.58
- Resistance Level
- CNVS $3.60
- ITRM $2.10
- Average True Range (ATR)
- CNVS 0.23
- ITRM 0.14
- MACD
- CNVS -0.05
- ITRM -0.04
- Stochastic Oscillator
- CNVS 28.57
- ITRM 11.11
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.